A purple and pink letter v on a white background.
September 3, 2019

Venus Legacy™ featured in W Magazine

In a recent online article, author Maryam Lieberman of W Magazine , sat down with celebrity facialist Candace Marino  to talk about her holistic approach to skin care and Venus Legacy™ treatments for skin tightening

In the article, Marino states that laxity can be a real issue for patients in their 40s, 50s, or 60s, but that it can impact younger clients, too. She mentions, "There are several options to help improve the look and feel of that 'crepy' skin. First and favorite is radio frequency, like Venus Legacy™, which is a non-invasive, no downtime treatment to tighten and improve the integrity of the skin." She further goes on to say, "These treatments can be done anywhere on the body [or face] and work best when done in a series but can definitely be a game changer. There is an insta-lifting effect I call it 'the Cinderella effect' because you'll be lifted and tight for about 24-48 hours..."

Venus Legacy ™ is a highly advanced system that uses non-invasive technology to resolve challenging face and body aesthetic needs, such as non-surgical body contouring*, cellulite reduction, skin tightening*, and wrinkle reduction. Treatments are comfortable with no downtime and the technology is safe for all skin types. Venus Legacy™ is powered by proprietary (MP) 2 technology and features cutting-edge VariPulse™ technology, which enhances the lipolysis effects of radio frequency energy, temporarily increases local blood circulation, and stimulates lymphatic drainage.

By Yoni Nowmalki July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.